Evofem Biosciences, Inc. (EVFM) |
| 0.009 -0 (-1.1%) 01-13 15:58 |
| Open: | 0.0094 |
| High: | 0.0094 |
| Low: | 0.009 |
| Volume: | 7,680 |
| Market Cap: | 1(M) |
| PE Ratio: | -0.18 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.04 |
| Resistance 1: | 0.03 |
| Pivot price: | 0.02 |
| Support 1: | 0.01 |
| Support 2: | 0.01 |
| 52w High: | 0.02 |
| 52w Low: | 0.006 |
Financials
| EPS | -1.400 |
| Book Value | -0.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.058 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 21 Nov 2025
Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PR Newswire
Thu, 13 Nov 2025
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PR Newswire
Mon, 20 Oct 2025
Evofem shareholders reject merger with Aditxt, company pivots to seek listing - Investing.com
Mon, 20 Oct 2025
Evofem Announces Voting Results from Special Meeting of Stockholders - Financial Times
Fri, 26 Sep 2025
Evofem Biosciences Honors World Contraception Day - PR Newswire
Thu, 11 Sep 2025
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
